Abstract
Purpose
Reconstructive surgeries following fractures in the maxillofacial region often involve considerable bone manipulation, and paracetamol is a commonly used analgesic medication in both intraoperative and postoperative periods. Dexmedetomidine, an alpha-2 adrenoceptor agonist, has both sedative and analgesic properties with minimal cardiorespiratory effects and has been used primarily for its sedative properties in oral and maxillofacial surgery.
Aims and Objectives
To compare the intraoperative analgesic requirements among patients undergoing oral and maxillofacial surgery who receive IV paracetamol versus IV dexmedetomidine. The time to requirement for the first postoperative analgesic dose and safety and adverse events of both medications were also assessed.
Patients and Methods
In total, 64 patients needing primary reconstructive surgery for facial fractures were recruited and divided into two groups for this double-blinded study. Patients were randomized to receive a preinduction dose of either IV paracetamol 1 g (Group P) or IV dexmedetomidine 1 µg/kg (Group D). Sedation scores (Ramsay sedation scale), maximal interincisal distance and pain scores at maximal mouth opening (visual analogue scale) were assessed in both groups just prior to and after the administration of the study drugs. After induction, Group P and Group D received a maintenance dose of normal saline and dexmedetomidine (0.5 µg/kg/h) during the intraoperative period, respectively. Standard noninvasive cardiorespiratory monitoring was done for the entire duration of surgery. Following extubation, postoperative pain scores and the time to request for first analgesic dose in either group were recorded.
Results
The time taken to perform the surgery was comparable in both groups. There was a significant difference between the groups in visual analogue scores and interincisal distance after the bolus dose (p < 0.05). Systolic and diastolic blood pressure was significantly lower in Group D at around 150 and 175 min of surgery. While the intraoperative fentanyl consumption was comparable in both groups, the time to request for the first analgesic dose in the postoperative period was significantly delayed in Group P (p < 0.05). No adverse cardiopulmonary events were observed in either group.
Conclusion
The intraoperative anesthetic and analgesic requirements and hemodynamic stability were comparable in IV paracetamol and dexmedetomidine groups. Dexmedetomidine did not confer any enhanced analgesia effect in the postoperative period. More research examining the role of dexmedetomidine for longer duration inpatient oral and maxillofacial surgery is needed.
Clinical Trial Number
http://ClinicalTrials.gov (No. CTRI/2017/08/009468).
Similar content being viewed by others
References
Alexander M, Krishnan B, Yuvaraj V (2009) Prophylactic antiemetics in oral and maxillofacial surgery: a requiem? J Oral Maxillofac Surg 67:1873–1877
Yeh F, Shessel B, Kaltman S (2012) The intraoperative use of multimodal analgesia in controlling postoperative pain in the orthognathic patient. J Oral Maxillofac Surg 70:E34–E35
Arslan M, Celep B, Ciçek R, Kalender HÜ, Yılmaz H (2013) Comparing the efficacy of preemptive paracetamol on the reducing effect of opioid usage in cholecystectomy. J Res Med Sci 18:172–177
Kramer KJ, Brady JW (2018) Anesthetic agents commonly used by oral and maxillofacial surgeons. Oral Maxillofac Surg Clin North Am 30:155–164
Singh V, Thepra M, Kirti S, Kumar P, Priya K (2018) Dexmedetomidine as an additive to local anesthesia: a step to development in dentistry. J Oral Maxillofac Surg. https://doi.org/10.1016/j.joms.2018.05.037
Davoudi A, Movahedian Attar B, Shadmehr E (2017) Risks and benefits of pre-operative dexmedetomidine in oral and maxillofacial surgeries: a systematic review. Expert Opin Drug Saf 16:711–720
Atencio I, Beushausen M, Kowalczyk JJ, Flores-Hidalgo A, Fino NF, Baur DA (2018) Use of intravenous acetaminophen in postoperative pain management after partial and full bony impacted third molar extractions: a randomized double-blind controlled trial. J Oral Maxillofac Surg 76:1414–1417
Guo TZ, Jiang JY, Buttermann AE, Maze M (1996) Dexmedetomidine injection into the locus ceruleus produces antinociception. Anesthesiology 84:873–881
Gurbet A, Basagan-Mogol E, Turker G, Ugun F, Kaya FN, Ozcan B (2006) Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth 53:646–652
Keniya VM, Ladi S, Naphade R (2011) Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Indian J Anaesth 55:352–357
Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ (2004) The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg 98:153–158
Tufanogullari B, White PF, Peixoto MP, Kianpour D, Lacour T, Griffin J et al (2008) Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg 106(6):1741–1748
Cortinez LI, Hsu YW, Sum-Ping ST, Young C, Keifer JC, Macleod D et al (2004) Dexmedetomidine pharmacodynamics: part II—crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 101:1077–1083
Swaika S, Parta N, Chattopadhyay S, Bisui B, Banarjee SS, Chattarjee S (2013) A comparative study of the efficacy of intravenous paracetamol and dexmedetomidine on peri-operative hemodynamics and post-operative analgesia for patients undergoing laparoscopic cholecystectomy. Anesth Essays Res 7:331–335
Sinatra RS, Jahr JS, Reynolds LW, Viscusi ER, Groudine SB, Payen-Champenois C (2005) Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology 102:822–831
Venn RM, Karol MD, Grounds RM (2002) Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 88:669–675
Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD (2000) The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93:382–394
Rummasak D, Apipan B (2014) Evaluation of the advantageous anesthetic properties of dexmedetomidine used as hypotensive agent compared with nitroglycerin in orthognathic surgery. J Oral Maxillofac Surg 72:2428–2433
Han LJ, Seok SJ, Young YJ, Hong KC, Kyo CI, Deok KY et al (2013) The effect of dexmedetomidine on post-operative care and hemodynamic patterns after bimaxillary orthognathic surgery. Int J Oral Maxfac Surg 42:1331
Simpson P (1992) Perioperative blood loss and its reduction: the role of the anaesthetist. Br J Anaesth 69:498–507
Durmus M, But AK, Dogan Z, Yucel A, Miman MC, Ersoy MO (2007) Effect of dexmedetomidine on bleeding during tympanoplasty or septorhinoplasty. Eur J Anaesthesiol 24:447–453
Richa F, Yazigi A (2007) Letter to editor. Effect of dexmedetomidine on blood pressure and bleeding in maxillofacial surgery. Eur J Anesth 24:985–986
Oliveira CR, Bernardo WM, Nunes VM (2017) Benefit of general anesthesia monitored by bispectral index compared with monitoring guided only by clinical parameters. Systematic review and meta-analysis. Braz J Anesthesiol 67:72–84
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declared that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Guru, K., Adinarayanan, S., Krishnan, B. et al. Comparative Evaluation of IV Paracetamol Versus IV Dexmedetomidine in Inpatient Oral and Maxillofacial Surgery: A Double-Blinded Randomized Controlled Study. J. Maxillofac. Oral Surg. 19, 394–400 (2020). https://doi.org/10.1007/s12663-019-01264-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12663-019-01264-3